Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
551 participants
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Water samples will be taken from the rooms of hospitalized patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Markers of Infection and Resistance in Invasive Fusariosis
NCT04937751
Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
NCT06498310
Surveillance of Fungal Infections During Construction Activity
NCT00473252
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
NCT00004938
Immunomonitoring of Mold Invasive Infections
NCT06285188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
with construction work
water samples
without construction work
water samples
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
water samples
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sautour PHRC IR 2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.